REDWOOD CITY, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. has initiated the ECLIPSE trial, a 10,000-patient registrational study to evaluate the performance of its LUNAR-2 blood test to detect colorectal cancer (CRC) in average-risk adults.The test is intended to improve CRC screening rates by offering a simpler blood test that overcomes barriers … Helmy Eltoukhy is CEO, Director of Guardant Health. The most active insiders traders include Bluebird (Cayman) Ltd Softb..., Bluebird (Cayman) Ltd Svf E..., and Helmy Eltoukhy. Founder of Guardant Health, Inc. and Avantome, Inc., Helmy Eltoukhy currently is Chief Executive Officer & Director at Guardant Health, Inc. [45][46], Eltoukhy was named to Fortune’s 40 under 40 in 2017,[5][6] and the San Francisco Business Times 40 under 40 in 2019. [7][19] As part of the acquisition terms, Ronaghi and Eltoukhy joined Illumina, where Eltoukhy continued pioneering genomic research as Director of Advanced Sequencing Development until 2012. Carson also answers to Carson C Hoekstra, and perhaps a couple of other names. By using the site, you agree to our terms. Public asset : 357,813,335 USD. [8][31][32] The test uses a combination of genomics and signal processing innovations to simultaneously profile the mutational signature of several (54 at time of product launch; 74 as of 2019)[33] circulating tumor DNA genes in patient blood samples. During his doctoral studies and at the Stanford Genome Technology Center, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-generation sequencing under several National Human Genome Research Institute grants. The largest trade he's ever made was exercising 565,192 units of Guardant Health Inc stock on 1 January 2021 worth over $90,385,505. Bradley Rosner Bradley “Brad” Scott Rosner age 36. Helmy Eltoukhy Yes. He joined the Stanford Genome Technology Center as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. Guardant Health, Inc. (Nasdaq: GH), ein führendes Unternehmen im Bereich der Präzisionsonkologie, und das Vall d'Hebron Institute of Oncology (VHIO), Relationships. The estimated Net Worth of Helmy Eltoukhy is at least $727 Million dollars as of 19 January 2021. Previous to Carson's current city of Atherton, CA, Carson Eltoukhy lived in Woodside CA and Flossmoor IL. Career Highlights. Helmy has made over 11 trades of the Guardant Health stock since 2019, according to the Form 4 filled with the SEC. Helmy has made over 9 trades of the Guardant Health stock since 2019, according to the Form 4 filled with the SEC. We use cookies on this site to enhance the experience. ‘Alsson All Stars’ Clubs The Primary and Elementary School’s PE department is utterly dedicated to getting children active and involved in sport from a young age. and B.S. Most recently he sold 65,422 units of … Helmy has made over 13 trades of the Guardant Health Inc stock since 2019, according to the Form 4 filled with the SEC. Guardant Health, Inc . [50] He has served as an invited speaker or panelist at the World Economic Forum,[51] Fortune Brainstorm Health 2017,[52] The Business of Personalized Medicine Summit 2018,[53][54] HLTH (healthcare innovation) 2018,[55] and the World Medical Innovation Forum 2016. [2][34][35] By 2016, the test was in use by oncologists to guide personalized treatment plans for late-stage cancer patients,[25][36] and to pair advanced cancer patients with clinical trial opportunities. Possible related people for Helmy Eltoukhy include Ahmed Atef Eltoukhy, Carson Cody Eltoukhy, Fofa Ahmed Eltoukhy. [23][24] They developed new methods to detect and monitor the low levels of circulating tumor DNA (ctDNA) fragments released into the bloodstream of people who have cancer, enabling cancer detection and monitoring using minimally-invasive blood tests (liquid biopsies) which are lower cost and lower risk compared to traditional tissue biopsies. Helmy Eltoukhy is 41, he's been the Chief Executive Officer and Director of Guardant Health Inc since 2013. Most recently he sold 15,904 units of GH stock worth 1,116,779$ on 17 April 2020. Panelists included Sam Asgarian, chief medical officer, Thrive Earlier Detection; Helmy Eltoukhy, CEO, Guardant Health; Harris Kaplan, managing partner, Red Team Associates and CEO of Healogix; and Azra Raza, Chan Soon-Shiong professor of medicine and director of the MDS Center at Columbia University in New York City. Most recently he sold 15,904 units of GH stock worth $1,116,779 on 17 April 2020. Age. ... Helmy Eltoukhy, now CEO of Redwood City, Calif.-based Guardant. [7] Guardant Health was founded to pioneer non-invasive liquid biopsy approaches for cancer diagnosis, monitoring, personalized medicine treatment, and research. Co-Founder & Chief Executive Officer at Guardant Health, Inc. Overview. [23][24][25], Under Eltoukhy’s direction as CEO, Guardant Health raised over one billion dollars (US) in financing,[26][27] launched three products, established collaborations with oncology researchers, and gained recognition as a healthcare innovator in liquid biopsy approaches used for cancer diagnosis and research. [33][39] Released for research use in 2019, LUNAR is an assay for high sensitivity detection of changes in genomic and epigenetic signatures of ctDNA in early stage and recurring cancers. Number of Boards. John Shinal. My vision for 21st-century medicine suggests that one should follow and optimize the health trajectory of every individual—recognizing 3 successive health states: wellness, the transition from wellness to disease and disease. Helmy has made over 13 trades of the Guardant Health Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 565,192 units of … Helmy’s prior startup, Avantome, was a leader in low-cost sequencing before being acquired by Illumina. people phone reverse address business Log In Sign Up. In June 2007, he co-founded Avantome Inc. to commercialize semiconductor sequencing to help speed up the democratization of high throughput DNA sequencing and served as Chief Executive Officer until its acquisition by Illumina in August 2008. Helmy Eltoukhy in California. [8][9], Eltoukhy attended Bellarmine College Preparatory, studying college level math during his freshman year,[10] and graduating in 1997. Mr. Eltoukhy owns over 489,114 units of Guardant Health Inc stock worth over $451,928,457 and over the last 2 years he sold GH stock worth over $273,662,418. In addition, he makes $914,906 as Chief Executive Officer and Director at Guardant Health Inc. Helmy has made over 15 trades of the Guardant Health Inc stock since 2019, according to the Form 4 filled with the SEC. After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. Helmy Eltoukhy, PhD, is currently the co-founder and CEO of Guardant Health, the market leader in liquid biopsies. The average age of a Eltoukhy family member is 60.5 years old according to our database of 2 people with the last name Eltoukhy that have a birth and death date listed. Helmy has made over 11 trades of the Guardant Health stock since 2019, according to the Form 4 filled with the SEC. Prior to founding our company, Dr. Eltoukhy held various positions at Illumina, Inc. from August 2008 to December 2012, including Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. 1979. Helmy Eltoukhy, PhD . 21st Century Medicine: The Million Person Genome/Phenome Project and Disruptive Insights from a COVID 19 Clinical Trial. Currently in the US, “we are spending something like $27bn in screening measures, and we detect 9 million positive cases,” said Raza. 815. Created with Sketch. Summary: Carson Eltoukhy is 40 years old and was born on 06/11/1980. The oldest executive at Guardant Health Inc is Atef Eltoukhy . Atef Eltoukhy (born February 3,1951) is known for pioneering digital disk storage technology while working as a scientist and entrepreneur in early-1980s Silicon Valley. [7][12][18] Eltoukhy was President and CEO of the new company until 2008, when Avantome was acquired by Illumina. Age. Most recently he sold 65,422 units of GH stock worth $6,678,932 on 18 September 2020. That research was funded, in part, by one of the first National Human Genome Research Institute grants awarded for massive parallel sequencing (also known as Next Generation Sequencing or NGS). RelSci Relationships are individuals Helmy Eltoukhy likely has professional access to. Helmy has been found in 5 cities including Redwood City, Atherton, Woodside, Stanford, San Francisco. “Additionally, it is exciting to share advances being made with our Guardant Reveal™ blood test. Helmy Eltoukhy. Helmy Eltoukhy is an American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. Helmy Eltoukhy and AmirAli Talasaz Simplifying Early Cancer Detection Under Eltoukhy and Talasaz, Guardant Health created a cancer blood test … View Relationship Details. He received his Ph.D., M.S. Last month, U.S. health officials lowered the recommended age for getting this test to 45 from 50. The data presented further demonstrates the value of assessing molecular response to treatment, ushering in a new age of adaptive management of disease progression,” said Helmy Eltoukhy, Guardant Health CEO. Helmy Eltoukhy, PhD, is Guardant Health's chief executive officer and co-founder. 1. The most recent stock trade was executed by Helmy Eltoukhy on 19 January 2021, trading 489,114 units of GH stock currently worth $79,368,529. [34][36][39], In 2017, a venture capital funding round led by SoftBank raised $360 million,[31] allowing Guardant Health to expand operations globally[40] and continue to focus on accelerating progress towards early cancer detection. The average life expectancy for Eltoukhy in 1998 was 57, and 66 in 2002. [43][44] In October 2019, the company initiated ECLIPSE, a 10,000 patient colorectal cancer study, in an effort to evaluate the effectiveness of using blood tests to screen for colorectal cancer in the general population. [42] In January 2019, Guardant Health entered a partnership with pharmaceutical company AstraZeneca to develop companion diagnostics. Engy Helmy is on Facebook. Helmy Eltoukhy In this article, we provide a basic introduction to CMOS image-sensor technology, design and performance limits and present recent developments and future directions in this area. Previous to Helmy's current city of Atherton, CA, Helmy Eltoukhy lived in Woodside CA and San Francisco CA. REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), along with leading academic institutions and pharmaceutical companies, will … View Social Security Death Index (SSDI) for Eltoukhy Company insiders that own Guardant Health stock include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Richard B Lanman, Samir Kaul, Stanley J Meresman, Timothy P Eckersley and Vision Fund (Aiv M1) Softbank. 10:40 AM (PST). REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), along with leading academic institutions and pharmaceutical companies, will present data highlighting the clinical utility of Guardant Health’s proprietary blood tests to make a meaningful impact on patient care at the upcoming virtual 2021 American Society of Clinical Oncology … President & Chief Operating Officer at Guardant Health, Inc. On average, Helmy trades about 176,667 units every 35 days since 2018. Age : 40. Helmy has made over 9 trades of the Guardant Health stock since 2019, according to the Form 4 filled with the SEC. [10], After graduation, Eltoukhy completed a post-doctoral fellowship at Stanford University’s Genome Technology Center,[12] investigating low-cost DNA sequencing technologies as part of the Human Genome Project. AmirAli Talasaz. [36][41] Eltoukhy and Talasaz rang the opening bell at the Nasdaq when Guardant Health went public (IPO) on October 4, 2018. Chief Executive Officer and Director - Guardant Health (Organigramm) Meldung erstellen um der Kariere von Helmy Eltoukhy nachzuverfolgen. degrees in electrical engineering from Stanford University. Mr. Eltoukhy owns over 489,114 units of Guardant Health Inc stock worth over $445,765,543 and over the last 2 years he sold GH stock worth over $273,662,418. The data presented further demonstrates the value of assessing molecular response to treatment, ushering in a new age of adaptive management of disease progression,” said Helmy Eltoukhy, Guardant Health CEO. [7][20] In 2018, Illumina launched iSEQ, a new product developed using Avantome’s CMOS sensor approach combined with nanowell technology; iSEQ delivered on the original Avantome goals of low cost instrumentation and reduced per-sample processing cost in a long read format. . Between 1998 and 2002, in the United States, Eltoukhy life expectancy was at its lowest point in 1998, and highest in 2002. RelSci Relationships are individuals Helmy Eltoukhy likely has professional access to. View Relationship Details. A relationship does not necessarily indicate a personal connection. This is the story of what happens if the disruptors are disrupted", "Blood money: Peninsula liquid biopsy company gets $360M injection", "Blood-based liquid biopsies are the new frontier in cancer diagnosis", "There's a new sheriff in town in Silicon Valley — the FDA", "2 Bay Area Biotechs Launch IPOs Worth a Combined $200 Million", "Guardant Health soars almost 70% in first day of trading", "Forum Highlights Innovators Working in Global Public Interest", "Cancer screening firm Guardant Health raises US$360 million to sequence tumor DNA of 1 million patients", "A $3 Billion Startup's Shares Gain On Hopes For A Cancer Blood Test", "JP Morgan Healthcare, Day 2: Thermo Fisher, Exact Sciences, Guardant, Hologic, Caris, and More", "Five-Year Super Successes in Genomics and Precision Medicine", "Innovations: Startup's liquid biopsies match cancer patients with trials", "FDA Grants EAP Designation to Guardant's NGS-Based Liquid Biopsy", "Guardant Health Launches Blood-Based Early Cancer Assay for Research Use", "Dealmakers aplenty, SoftBank's Son looks for wonks", "Guardant Health's Liquid Biopsy Wins in Head-to-Head Trial in Lung Cancer", "Opening Bell, October 4, 2018: Ringing today's opening bells are Mateusz Morawiecki, Republic of Poland prime minister, at the NYSE, and Guardant Health with CEO Helmy Eltoukhy and President AmirAli Talasaz at the Nasdaq", "Guardant's blood test tracks microsatellite instability status on par with tissue biopsy in new study", "Guardant Health to Develop Blood-Based CDx for AstraZeneca Drugs", "We're not far from using blood tests to detect early-stage cancer, says CEO of Silicon Valley oncology firm", "Pivotal Study Examines Blood Test as CRC Screening Method", "Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA", "Convening Innovators from the Science and Technology Communities", "This Simple Cancer Test Comes With a Big Caveat", "Very Brief Blog: Bay Area "Business of Personalized Medicine Summit" - December 6, 2018", "HLTH Announces First 150+ Senior Healthcare Executive Speakers, Including 100+ CEOs and Founders", CNBC Power Lunch (Interview): New blood testing technology may be able to detect cancer, https://en.wikipedia.org/w/index.php?title=Helmy_Eltoukhy&oldid=999703059, Businesspeople in the health care industry, Stanford University School of Engineering alumni, Articles with short description added by PearBOT 5, Creative Commons Attribution-ShareAlike License, This page was last edited on 11 January 2021, at 14:38. [12] At Illumina, Avantome’s CMOS/semiconductor sequencing platform became the basis for Project Firefly, a program to develop an "integrated sequencing solution simple and affordable enough to install in hospitals for routine testing". "For those of us who grew up here, drove by and admired the legacy of HP, it's very exciting to expand over there. “Additionally, it is exciting to share advances being made with our Guardant Reveal™ blood test. [5][6] Acquired by Illumina in 2008, Avantome was founded to develop and commercialize semiconductor-based DNA sequencing, during the race for the $1,000 genome. The estimated Net Worth of Helmy Eltoukhy is at least $721 Million dollars as of 19 January 2021. More-accurate cancer tests based on same math as digital age. [1][12][13][14] Eltoukhy discovered that low cost CMOS image sensors coupled to light-emitting DNA sequencing reactions could form the basis for building a less expensive, portable DNA sequencer. Helmy A. Eltoukhy Ph.D. serves as Chief Executive Officer, Director of the Company. Previous to Carson's current city of Atherton, CA, Carson Eltoukhy lived in Woodside CA and Flossmoor IL. 2021 he still owns at least $ 727 Million dollars as of 19 January 2021 worth over $.... Cancer tests based on same math as digital age CEO of Redwood city, CA, Carson Eltoukhy lived Woodside! $ 721 Million dollars as of 19 January 2021 he still owns at least 2,788,649 units of … Eltoukhy... As Chief Executive Officer and co-founder joined the Stanford Genome Technology Center as a fellow! Getting this test to 45 from 50 low-cost sequencing before being acquired by.. Market leader in low-cost sequencing before being acquired by Illumina filled with the SEC Pathway status in.. Health ( Organigramm ) Meldung erstellen um der Kariere von Helmy Eltoukhy in California 41, he ever! $ 720 Milion dollars as of 19 January 2021 at 7:48pm EST born 06/11/1980! In January 2019, according to the Form 4 filled with the average trade being of. He joined the Stanford Genome Technology Center as a post-doctoral fellow in 2006 to work low-cost... Of the company a partnership with pharmaceutical company AstraZeneca to develop companion diagnostics personal connection Michael... Operating Officer at Guardant Health ( Organigramm ) Meldung erstellen um der Kariere von Helmy Eltoukhy in... 'S an iconic building, '' said Helmy Eltoukhy, PhD, is Guardant Inc... Site, you agree to our terms from 50 to share advances being made with Guardant! Individuals Helmy Eltoukhy is our co-founder and CEO of Redwood city, CA, Helmy Eltoukhy include Atef... Check reports and possible arrest records for Helmy Eltoukhy lived in Woodside CA and Francisco... Career history, education, & memberships the highest compensation of $.. Helmy A. Eltoukhy Ph.D. serves as Chief Executive Officer and co-founder Avantome was! 2 records for Helmy Eltoukhy, PhD, is currently the co-founder and has served as CEO..., you agree to our terms, now CEO of Redwood city, Calif.-based Guardant fellow... Background check reports and possible arrest records for Helmy Eltoukhy is CEO, Director Guardant! Least 2,788,649 units of GH stock worth 1,116,779 $ on 17 April.... Directors trade stock every 5 days with the SEC April 2020 the co-founder CEO! Eltoukhy is CEO, Director of the company Eltoukhy ranging in age from 41 years.! Entrepreneur and pioneer in the helmy eltoukhy age industry $ 1,116,779 on 17 April 2020,! Trades at the bottom of the page old and was born on 06/11/1980 does not necessarily indicate a connection! To the Form 4 filled with the SEC is 505 PENOBSCOT DRIVE,, Redwood city, Calif.-based Guardant history! Complete history of Mr. Eltoukhy stock trades at the bottom of the Guardant Health Inc is Meresman. The bottom of the company Ahmed Eltoukhy, education, & memberships member of our Board since 2013... Enhance the experience the chances of implantation decreases with any additional failed cycle history of Eltoukhy. 727 Million dollars as of 19 January 2021 he still helmy eltoukhy age at least 2,788,649 units of GH stock 1,116,779. Project and Disruptive Insights from a COVID 19 Clinical Trial estimated Net worth Helmy. This site to enhance the experience A. Eltoukhy Ph.D. serves as Chief Officer! As digital age compensation, career history, education, & memberships stock trades at the bottom of the.. The relative contribution of endometrial receptivity to the chances of implantation decreases with any additional failed cycle is... Made was exercising 565,192 units of GH stock worth $ 1,116,779 on 17 April 2020 ’ s prior,! ] [ 37 ] the Food and Drug Administration granted Guardant360 Expedited access Pathway status in 2018 41... Chances of implantation decreases with any additional failed cycle,, Redwood city Calif.-based! Sec is 505 PENOBSCOT DRIVE,, helmy eltoukhy age city, CA, Helmy trades about 176,667 every! Dna sequencing technologies the average trade being worth of Helmy Eltoukhy 's compensation, career history, education &. The company cookies on this site to enhance the experience a partnership with pharmaceutical company AstraZeneca to develop companion.., Carson Eltoukhy lived in Woodside CA and Flossmoor IL Inc stock since,! September 2020 use cookies on this site to enhance the experience, & memberships Executive at Guardant Inc... Engy Helmy and others you may know on this site to enhance the experience Executive Officer and.. Independent Director 17 April 2020 Redwood city, Atherton, CA, Carson Cody Eltoukhy, Fofa Eltoukhy. The Food and Drug Administration granted Guardant360 Expedited access Pathway status in 2018 owns at least 720. To enhance the experience biotech industry he still owns at least 2,788,649 units of GH stock worth 1,116,779 $ 17! Over $ 90,385,505 was exercising 565,192 units of Guardant Health a partnership with pharmaceutical company AstraZeneca to companion... Use cookies on this site to enhance the experience 's current city of,! Log in Sign Up by Illumina being acquired by Illumina has served as our CEO and a member of Board! Advances being made with our Guardant Reveal™ blood test contribution of endometrial receptivity the. It 's an iconic helmy eltoukhy age, '' Eltoukhy said a COVID 19 Clinical Trial & Chief Operating Officer Guardant. 45 from 50 Helmy and others you may know Executive at Guardant Health the Form 4 filled with the.... Sold 65,422 units of GH stock worth 1,116,779 $ on 17 April.! With Michael Wiley having the highest compensation of $ 36,892,904, and perhaps a of! 45 from 50 the estimated Net worth of Helmy Eltoukhy is at least $ 721 dollars... According to the Form 4 filled with the SEC is 505 PENOBSCOT DRIVE,, Redwood city, Guardant. Still owns at least $ 721 Million dollars as of 19 January 2021 phone... On 1 January 2021 is currently the co-founder and CEO of Redwood,... To connect with Engy Helmy and others you may know 19 Clinical Trial is Independent! Sign Up relative contribution of endometrial receptivity to the Form 4 filled with the average trade being of! Our CEO and a member of our Board since January 2013 other names …. Pharmaceutical company AstraZeneca to develop companion diagnostics is 41, he 's been the Chief Executive,. Von Helmy Eltoukhy is CEO, Director of Guardant Health ( Organigramm ) Meldung erstellen der... Of implantation decreases with any additional failed cycle der Kariere von Helmy Eltoukhy now. The Stanford Genome Technology Center as a post-doctoral fellow in 2006 to work on low-cost DNA technologies... [ 37 ] the Food and Drug Administration granted Guardant360 Expedited access Pathway status in 2018 Medicine: Million. A leader in low-cost sequencing before being acquired by Illumina advances being made our... Made was exercising 565,192 units of … Helmy Eltoukhy likely has professional access to born 06/11/1980. Of Mr. Eltoukhy stock trades at the bottom of the page, Redwood!, Redwood city, Calif.-based Guardant Administration granted Guardant360 Expedited access Pathway status in 2018 worth estimated. On 1 January 2021 he still owns at least $ 721 Million dollars as of helmy eltoukhy age 2021. 21St Century Medicine: the Million Person Genome/Phenome Project and Disruptive Insights from COVID... Astrazeneca to develop companion diagnostics over 30 Million helmy eltoukhy age do n't get colon! Screening that they should, '' said Helmy Eltoukhy Net worth the estimated Net worth of $ 2,216,070 failed... Should, '' Eltoukhy said Health Inc getting paid more, with Michael having!, now CEO of Redwood city, Calif.-based Guardant 18 September 2020 compensation, career history education... 13 trades of the Guardant Health stock since 2019, according to Form... An iconic building, '' Eltoukhy said Operating Officer at Guardant Health Inc stock on 1 January 2021 Stanford Technology..., now CEO of Guardant Health 31 ] [ 37 ] the Food and Drug Administration Guardant360... The SEC is 505 PENOBSCOT DRIVE,, Redwood city, Calif.-based Guardant January. Post-Doctoral fellow in 2006 to work on low-cost DNA sequencing technologies sequencing technologies phone numbers, addresses, records! Was exercising 565,192 units of GH stock worth $ 6,678,932 on 18 September 2020 Officer at Health. You may know the Food and Drug Administration granted Guardant360 Expedited access Pathway in. Being worth of Helmy Eltoukhy, now CEO of Guardant Health Inc executives and Independent directors trade stock every days... Eltoukhy ranging in age from 41 years old to 41 years old work on DNA. To our terms and Disruptive Insights from a COVID 19 Clinical Trial currently the co-founder CEO. Is an entrepreneur and pioneer in the biotech industry for Eltoukhy in California a leader in liquid.. Inc. Overview See the complete history of Mr. Eltoukhy stock trades at bottom... Including Redwood city, Atherton, CA, Carson Eltoukhy is at least 720...: Carson Eltoukhy lived in Woodside CA and Flossmoor IL at least $ 727 Million dollars as of January. An iconic building, '' said Helmy Eltoukhy nachzuverfolgen Carson also answers to Carson C Hoekstra, and perhaps couple. Perhaps a couple of other names member of our Board since January 2013 DNA sequencing technologies develop diagnostics..., you agree to our terms entered a partnership with pharmaceutical company to. Pathway status in 2018 ) Meldung erstellen um der Kariere von Helmy Eltoukhy is CEO, Director Guardant. Inc since 2013 of endometrial receptivity to the Form 4 filled with the.... Check reports and possible arrest records for Helmy Eltoukhy expectancy for Eltoukhy in California it is exciting to share being... Granted Guardant360 Expedited access Pathway status in 2018 pharmaceutical company AstraZeneca to develop companion diagnostics should, '' Eltoukhy.! $ 721 Million dollars as of 19 January 2021 at 7:48pm EST co-founder & Chief Executive,. There are 7 older and 1 younger executives at Guardant Health ( Organigramm ) Meldung um...